Welcome to our dedicated page for Markel Corporation SEC filings (Ticker: MKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Markel Group Inc. (NYSE: MKL) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports, periodic reports, and other documents filed with the U.S. Securities and Exchange Commission. As a diversified group built around specialty insurance, industrial, financial, and consumer businesses, Markel Group uses its filings to present segment results, capital allocation, and key changes in financial reporting.
Among the filings, investors can find current reports on Form 8-K that announce material events, such as the release of quarterly and nine-month financial results and changes to segment reporting. For example, an 8-K filing describes notable changes to Markel Group’s financial reporting, including the re-segmentation of its businesses and the expansion of consolidated and segment financial metrics, accompanied by a Reporting Changes Guide furnished as an exhibit.
The filings set also includes Form 10-Q references, where Markel Group discusses operating revenues, operating income, adjusted operating income, and segment performance for Markel Insurance, Industrial, Financial, and Consumer and Other. These documents provide detailed information on how the company measures performance over time and how its specialty insurance operations support the broader system of businesses and investments.
Investors may also encounter specialized filings such as Form 15 related to specific plans. In one case, a Form 15 filing for the Costa Farms, LLC 401(k) Plan explains the termination of an investment option linked to Markel Group common shares and clarifies that this suspension of the plan’s reporting obligations does not affect Markel Group Inc.’s duty to file reports for its common shares.
On Stock Titan, these filings are paired with AI-powered summaries designed to highlight the main points of each document. Users can quickly see which exhibits were furnished with an 8-K, how segment results are evolving in quarterly reports, and how non-GAAP measures such as adjusted operating income are defined and used by the company. This page is a resource for understanding Markel Group’s regulatory history, segment disclosures, and the financial context behind its specialty insurance and diversified business activities.
Markel Group Inc. is asking shareholders to vote at its May 20, 2026 annual meeting on electing 11 directors, approving executive pay on an advisory basis, and ratifying KPMG LLP as auditor. KPMG billed $11,314,787 in aggregate fees for 2025.
The Board also seeks approval of an amendment to the Articles of Incorporation that would, where Virginia law permits, replace certain default supermajority voting requirements with a majority-of-votes-entitled standard for major corporate actions, requiring more than two‑thirds of outstanding shares to pass. Shareholders will vote on two proposals: one requesting a report on environmental risk strategies and one to allow 10% holders to call special meetings; the Board recommends voting against both.
As of March 12, 2026, there were 12,547,039 common shares outstanding. The Vanguard Group and BlackRock, Inc. beneficially owned 9.50% and 6.08% of the stock, respectively.
Markel Group Inc Schedule 13G/A amendment reports that The Vanguard Group holds 0 shares of Common Stock, representing 0% of the class. The filing notes an internal realignment on 2026-01-12 under SEC Release No. 34-39538, after which certain Vanguard subsidiaries report holdings separately and The Vanguard Group is no longer deemed to beneficially own those securities. The amendment is signed by Ashley Grim on 03/27/2026.
The Board of Markel Group Inc. is soliciting proxies for the 2026 Annual Meeting of Shareholders to be held on May 20, 2026. Key items include election of eleven director nominees, an advisory vote on executive compensation, ratification of KPMG LLP as auditor, and a proposed amendment to the Articles of Incorporation. Shareholder proposals include a request for a report on environmental risk strategies and a proposal to lower the ownership threshold to call special meetings; the Board recommends voting FOR the Article amendment and AGAINST the shareholder proposals. The record date for voting is March 12, 2026. The proxy materials and the 2025 Annual Report are available online at the Company’s proxy materials site.
Costanzo Brian J. reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. Chief Financial Officer Brian J. Costanzo reported an equity award of 654.641 shares of common stock in the form of restricted stock units granted at a price of $0.0000 per share on February 24, 2026.
According to the award terms, 539.739 RSUs are scheduled to vest on December 31, 2028, and 114.902 RSUs are scheduled to vest on February 24, 2029, subject to specified conditions. After this grant, he directly holds 1,611.1836 shares and indirectly holds 223.836 shares through a 401(k) plan based on the balance as of December 31, 2025.
MARKEL GROUP INC. executive Andrew G. Crowley, EVP & President of Markel Ventures, reported an equity award tied to 830.0200 shares of common stock on a grant, award, or other acquisition basis at a stated price of $0.0000 per share.
According to the footnotes, these are restricted stock units under the MKL 2024 Equity Incentive Compensation Plan, with 693.951 RSUs scheduled to vest on December 31, 2028, and 136.069 RSUs on February 24, 2029. After this grant, Crowley directly holds 2,743.7464 shares of common stock and indirectly holds 205.2520 shares through a MKL 401(k) plan, based on the plan balance as of December 31, 2025.
Grinnan Richard Randolph reported acquisition or exercise transactions in this Form 4 filing.
Markel Group Inc. senior vice president and chief legal officer Richard Randolph Grinnan received a grant of 800.508 shares of common stock on February 24, 2026, reported as a stock award with no cash price per share.
The award consists of restricted stock units under the MKL 2024 Equity Incentive Compensation Plan. According to the footnotes, 669.277 RSUs are scheduled to vest on December 31, 2028, and 131.231 RSUs are scheduled to vest on February 24, 2029, subject to conditions. After this grant, Grinnan directly holds 4,263.4279 common shares and indirectly holds 117.099 shares through the MKL 401(k) plan, based on the plan balance as of December 31, 2025.
MARKEL GROUP INC. executive Meade P. Grandis, CAO and Controller, reported an award of 69.722 restricted stock units of common stock on February 24, 2026 at no cost under the MKL 2024 Equity Incentive Compensation Plan. According to the footnotes, 58.292 RSUs are scheduled to vest on December 31, 2028 and 11.430 RSUs on February 24, 2029, subject to conditions. The filing also updates indirect ownership balances held through a 401(k) plan, trusts, the reporting person’s spouse, and children, including a prior 2.026-share acquisition in the MKL 401(k) plan between June 30, 2025 and December 31, 2025 and a 275-share distribution from trusts to the spouse.
Markel Group Inc. reported that Chief Executive Officer Thomas Sinnickson Gayner acquired 4,483.616 shares of common stock through a grant of restricted stock units on February 24, 2026. The award was made under the MKL 2024 Equity Incentive Compensation Plan at a price of $0 per share.
According to a footnote, 3,731.912 RSUs are scheduled to vest on December 31, 2028, and 751.704 RSUs are scheduled to vest on February 24, 2029, subject to certain conditions. After this grant, Gayner directly owns 56,741.3334 common shares and also reports indirect holdings through a trust, spouse, and a 401(k) plan, with the 401(k) balance based on figures as of December 31, 2025.
Markel Group executive Wilson Simon reported both a stock sale and an equity award. On February 26, 2026, he completed an open-market sale of 100 shares of Markel Group common stock at a price of $2,079.4848 per share, leaving him with 2,396.7456 directly owned shares.
On February 24, 2026, he received a grant of 868.117 restricted stock units under the MKL 2024 Equity Incentive Compensation Plan at no purchase price. According to the award terms, 629.914 RSUs are scheduled to vest on December 31, 2028, and 238.203 RSUs are scheduled to vest on February 24, 2029, subject to applicable conditions.